ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 124 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q2 2021. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $117,000 | -38.1% | 54,095 | 0.0% | 0.00% | – |
Q2 2021 | $189,000 | -96.7% | 54,095 | -90.7% | 0.00% | -100.0% |
Q1 2021 | $5,708,000 | -68.2% | 578,926 | -65.1% | 0.00% | -50.0% |
Q4 2020 | $17,967,000 | +65.3% | 1,657,433 | +57.1% | 0.00% | +100.0% |
Q3 2020 | $10,868,000 | -75.5% | 1,055,133 | -50.3% | 0.00% | -83.3% |
Q2 2020 | $44,363,000 | +85.1% | 2,124,648 | -13.4% | 0.01% | +50.0% |
Q1 2020 | $23,969,000 | +66.2% | 2,453,366 | +96.0% | 0.00% | +100.0% |
Q4 2019 | $14,421,000 | +153.0% | 1,251,787 | +19.7% | 0.00% | +100.0% |
Q3 2019 | $5,701,000 | -14.1% | 1,046,102 | +87.5% | 0.00% | 0.0% |
Q2 2019 | $6,635,000 | – | 558,036 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sonic Fund II, L.P. | 6,552,068 | $14,218,000 | 8.03% |
Versant Venture Management, LLC | 5,068,233 | $10,998,000 | 4.55% |
K2 PRINCIPAL FUND, L.P. | 1,653,874 | $3,589,000 | 0.29% |
RTW INVESTMENTS, LP | 7,483,757 | $16,240,000 | 0.24% |
Avoro Capital Advisors LLC | 6,950,000 | $15,082,000 | 0.24% |
Artal Group S.A. | 3,000,000 | $6,510,000 | 0.15% |
ALGERT GLOBAL LLC | 231,490 | $502,000 | 0.07% |
Virtus ETF Advisers LLC | 57,768 | $125,000 | 0.06% |
Pinz Capital Management, LP | 53,600 | $116,000 | 0.05% |
TWIN FOCUS CAPITAL PARTNERS, LLC | 100,000 | $217,000 | 0.05% |